These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36855409)

  • 1. A trial of topiramate for patients with hereditary spinocerebellar ataxia.
    Miura S; Sawada R; Yorita A; Kida H; Kamada T; Yamanishi Y
    Clin Case Rep; 2023 Feb; 11(2):e6980. PubMed ID: 36855409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese kindreds.
    Tang B; Liu C; Shen L; Dai H; Pan Q; Jing L; Ouyang S; Xia J
    Arch Neurol; 2000 Apr; 57(4):540-4. PubMed ID: 10768629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gait characteristics and clinical relevance of hereditary spinocerebellar ataxia on deep learning.
    Jin L; Lv W; Han G; Ni L; Sun D; Hu X; Cai H
    Artif Intell Med; 2020 Mar; 103():101794. PubMed ID: 32143799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency of spinocerebellar ataxia types 1,2,3,6,7 and dentatorubral pallidoluysian atrophy mutations in Korean patients with spinocerebellar ataxia.
    Jin DK; Oh MR; Song SM; Koh SW; Lee M; Kim GM; Lee WY; Chung CS; Lee KH; Im JH; Lee MJ; Kim JW; Lee MS
    J Neurol; 1999 Mar; 246(3):207-10. PubMed ID: 10323319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetics of hereditary spinocerebellar ataxia: mutation analysis of spinocerebellar ataxia genes and CAG/CTG repeat expansion detection in 225 Italian families.
    Brusco A; Gellera C; Cagnoli C; Saluto A; Castucci A; Michielotto C; Fetoni V; Mariotti C; Migone N; Di Donato S; Taroni F
    Arch Neurol; 2004 May; 61(5):727-33. PubMed ID: 15148151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of acetyl-DL-leucine on cerebellar ataxia (ALCAT trial): study protocol for a multicenter, multinational, randomized, double-blind, placebo-controlled, crossover phase III trial.
    Feil K; Adrion C; Teufel J; Bösch S; Claassen J; Giordano I; Hengel H; Jacobi H; Klockgether T; Klopstock T; Nachbauer W; Schöls L; Stendel C; Uslar E; van de Warrenburg B; Berger I; Naumann I; Bayer O; Müller HH; Mansmann U; Strupp M
    BMC Neurol; 2017 Jan; 17(1):7. PubMed ID: 28068987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Various Movement Disorders in Patients of Genetically Proven Spinocerebellar Ataxia: A Study from a Tertiary Care Center in Northern India.
    Radhakrishnan DM; Goyal V; Srivastava AK; Shukla G; Behari M
    Ann Indian Acad Neurol; 2018; 21(1):24-28. PubMed ID: 29720794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment for speech disorder in Friedreich ataxia and other hereditary ataxia syndromes.
    Vogel AP; Folker J; Poole ML
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD008953. PubMed ID: 25348587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repetitive Transcranial Magnetic Stimulation in Spinocerebellar Ataxia: A Pilot Randomized Controlled Trial.
    Manor B; Greenstein PE; Davila-Perez P; Wakefield S; Zhou J; Pascual-Leone A
    Front Neurol; 2019; 10():73. PubMed ID: 30809184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic and Genotypic Analysis of Hereditary Ataxia Patients in Sakarya City, Turkey.
    Sayan S; Kotan D; Gündoğdu-Eken A; Şahbaz I; Koçoğlu C; Başak AN
    Noro Psikiyatr Ars; 2019 Jun; 56(2):106-109. PubMed ID: 31223241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of Robotic Exoskeleton-Assisted Gait Training in Spinocerebellar Ataxia: A Case Report.
    Kim SH; Han JY; Song MK; Choi IS; Park HK
    Sensors (Basel); 2021 Jul; 21(14):. PubMed ID: 34300613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of riluzole in spinocerebellar ataxia type 2 in France (ATRIL): a multicentre, randomised, double-blind, placebo-controlled trial.
    Coarelli G; Heinzmann A; Ewenczyk C; Fischer C; Chupin M; Monin ML; Hurmic H; Calvas F; Calvas P; Goizet C; Thobois S; Anheim M; Nguyen K; Devos D; Verny C; Ricigliano VAG; Mangin JF; Brice A; Tezenas du Montcel S; Durr A
    Lancet Neurol; 2022 Mar; 21(3):225-233. PubMed ID: 35063116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Riluzole in patients with hereditary cerebellar ataxia: a randomised, double-blind, placebo-controlled trial.
    Romano S; Coarelli G; Marcotulli C; Leonardi L; Piccolo F; Spadaro M; Frontali M; Ferraldeschi M; Vulpiani MC; Ponzelli F; Salvetti M; Orzi F; Petrucci A; Vanacore N; Casali C; Ristori G
    Lancet Neurol; 2015 Oct; 14(10):985-91. PubMed ID: 26321318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreasing fall risk in spinocerebellar ataxia.
    Santos de Oliveira LA; Martins CP; Horsczaruk CH; Lima da Silva DC; Martins JV; Vasconcelos LF; Rodrigues Ede C
    J Phys Ther Sci; 2015 Apr; 27(4):1223-5. PubMed ID: 25995594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Distribution of dominant hereditary ataxias and Friedreich's ataxia in the Spanish population].
    Mayo Cabrero D; Hernández Cristóbal J; Cantarero Duque S; Martínez Delgado B; Urioste Azcorra M; Robledo Batanero M; García-Ruiz Espiga P; Benítez Ortiz J
    Med Clin (Barc); 2000 Jun; 115(4):121-5. PubMed ID: 10996881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of Spinocerebellar Ataxia type 1, 2, 3,6 and 7 and clinical profile of Spinocerebellar Ataxia type 3 in Malaysia.
    Mohamed Ibrahim N; Lau YH; Ariffin N; Md Desa SH; Azizan E; Chin LK; Md Rani SA; Yakob Y; Datuk Puvanarajah S; van de Warrenburg B
    Cerebellum Ataxias; 2020; 7():11. PubMed ID: 32922823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Cardiac Autonomic Function in Type 2 Spinocerebellar Ataxia With Normal Control Using Heart Rate Variability as a Tool: A Cross-Sectional Study in Eastern India.
    Senapati LK; Patnaik S; Samanta P; Kar SP; Dash S; Mishra J
    Cureus; 2021 Nov; 13(11):e20058. PubMed ID: 34873557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of spinocerebellar ataxia types 1, 2, 3, and 6, dentatorubral-pallidoluysian atrophy, and Friedreich's ataxia genes in spinocerebellar ataxia patients in the UK.
    Leggo J; Dalton A; Morrison PJ; Dodge A; Connarty M; Kotze MJ; Rubinsztein DC
    J Med Genet; 1997 Dec; 34(12):982-5. PubMed ID: 9429138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of umbilical cord mesenchymal stem cell therapy in hereditary spinocerebellar ataxia.
    Jin JL; Liu Z; Lu ZJ; Guan DN; Wang C; Chen ZB; Zhang J; Zhang WY; Wu JY; Xu Y
    Curr Neurovasc Res; 2013 Feb; 10(1):11-20. PubMed ID: 23151076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of topiramate in refractory epilepsy: a long-term prospective trial.
    Tartara A; Sartori I; Manni R; Galimberti CA; Di Fazio M; Perucca E
    Ital J Neurol Sci; 1996 Dec; 17(6):429-32. PubMed ID: 8978450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.